MAGE – Multiplex Automated Genome Engineering Generates Billions of Variants: The Digest’s 2020 Multi-Slide Guide to enEvolv’s Genome Engineering

enEvolv produces biobased chemicals for the energy, specialty chemicals, nutrition and therapeutics industries, develops novel strains and improves existing ones focusing on their ultra-rapid genome engineering platform.

Marco Farsheed, enEvolv’s Co-Founder and CEO shared this illuminating presentation on why strain engineering is challenging, how enEvolv’s variation technology improves the economics and effectiveness of strain engineering which is helpful for alternate feedstocks, fermentation conditions, and more.